AG2R LA Mondiale Gestion D Actifs Makes New $2.68 Million Investment in Colgate-Palmolive Company $CL

Key Points

• AG2R LA Mondiale Gestion D Actifs made a new investment in Colgate-Palmolive Company, acquiring 28,826 shares valued at approximately $2.68 million.
• Colgate-Palmolive recently reported quarterly earnings of $0.92 EPS, surpassing analyst expectations of $0.89, with a revenue of $5.11 billion.
• The company declared a quarterly dividend of $0.52 per share, representing an annualized yield of 2.5%, with a payout ratio of 58.43%.

AG2R LA Mondiale Gestion D Actifs acquired a new position in Colgate-Palmolive Company (NYSE:CL - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 28,826 shares of the company's stock, valued at approximately $2,679,000.

A number of other institutional investors and hedge funds have also made changes to their positions in CL. Brighton Jones LLC grew its stake in shares of Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock worth $962,000 after buying an additional 450 shares in the last quarter. Bernard Wealth Management Corp. purchased a new position in shares of Colgate-Palmolive in the 4th quarter worth $36,000. NorthRock Partners LLC grew its stake in shares of Colgate-Palmolive by 105.3% in the 4th quarter. NorthRock Partners LLC now owns 8,409 shares of the company's stock worth $764,000 after buying an additional 4,314 shares in the last quarter. Pathstone Holdings LLC lifted its holdings in shares of Colgate-Palmolive by 2.3% in the 4th quarter. Pathstone Holdings LLC now owns 91,226 shares of the company's stock worth $8,292,000 after acquiring an additional 2,069 shares during the last quarter. Finally, Rafferty Asset Management LLC lifted its holdings in shares of Colgate-Palmolive by 12.4% in the 4th quarter. Rafferty Asset Management LLC now owns 70,918 shares of the company's stock worth $6,447,000 after acquiring an additional 7,849 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Down 0.8%

Shares of CL opened at $83.35 on Friday. Colgate-Palmolive Company has a 1-year low of $82.29 and a 1-year high of $106.26. The company has a 50-day moving average of $85.95 and a 200 day moving average of $89.55. The firm has a market capitalization of $67.37 billion, a price-to-earnings ratio of 23.41, a PEG ratio of 4.37 and a beta of 0.35. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter last year, the business posted $0.91 EPS. The firm's revenue for the quarter was up 1.0% on a year-over-year basis. On average, research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be issued a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. Colgate-Palmolive's payout ratio is currently 58.43%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a report on Monday, August 4th. JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a report on Monday, August 4th. Barclays raised their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 15th. Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a report on Monday, August 4th. Finally, UBS Group lowered their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Seven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of "Moderate Buy" and an average price target of $98.00.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.